img

Global Carbapenem Antibiotics Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Carbapenem Antibiotics Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Carbapenem Antibiotics report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Carbapenem Antibiotics market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Retail Pharmacy and Online Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Carbapenem Antibiotics industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Carbapenem Antibiotics key manufacturers include ACS Dobfar S.p.A, Iterum Therapeutics plc, DAEWOONG PHARMACEUTICAL CO.,LTD, Aurobindo Pharma Ltd, Gland Pharma Limited, Merck & Co., Inc., Sumitomo Dainippon Pharma Co., Ltd., Savior Lifetec and Pfizer Inc., etc. ACS Dobfar S.p.A, Iterum Therapeutics plc, DAEWOONG PHARMACEUTICAL CO.,LTD are top 3 players and held % sales share in total in 2022.
Carbapenem Antibiotics can be divided into Meropenem, Donipenem, Imipenem and Tipipenem, etc. Meropenem is the mainstream product in the market, accounting for % sales share globally in 2022.
Carbapenem Antibiotics is widely used in various fields, such as Retail Pharmacy, Online Pharmacy and Hospital Pharmacy,, etc. Retail Pharmacy provides greatest supports to the Carbapenem Antibiotics industry development. In 2022, global % sales of Carbapenem Antibiotics went into Retail Pharmacy filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Carbapenem Antibiotics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


ACS Dobfar S.p.A
Iterum Therapeutics plc
DAEWOONG PHARMACEUTICAL CO.,LTD
Aurobindo Pharma Ltd
Gland Pharma Limited
Merck & Co., Inc.
Sumitomo Dainippon Pharma Co., Ltd.
Savior Lifetec
Pfizer Inc.
Spero Therapeutics
Segment by Type
Meropenem
Donipenem
Imipenem
Tipipenem
Others

Segment by Application


Retail Pharmacy
Online Pharmacy
Hospital Pharmacy

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Carbapenem Antibiotics market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Carbapenem Antibiotics, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Carbapenem Antibiotics industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Carbapenem Antibiotics in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Carbapenem Antibiotics introduction, etc. Carbapenem Antibiotics Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Carbapenem Antibiotics market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Carbapenem Antibiotics Market Overview
1.1 Carbapenem Antibiotics Product Overview
1.2 Carbapenem Antibiotics Market Segment by Type
1.2.1 Meropenem
1.2.2 Donipenem
1.2.3 Imipenem
1.2.4 Tipipenem
1.2.5 Others
1.3 Global Carbapenem Antibiotics Market Size by Type
1.3.1 Global Carbapenem Antibiotics Market Size Overview by Type (2024-2034)
1.3.2 Global Carbapenem Antibiotics Historic Market Size Review by Type (2024-2024)
1.3.3 Global Carbapenem Antibiotics Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Carbapenem Antibiotics Sales Breakdown by Type (2024-2024)
1.4.2 Europe Carbapenem Antibiotics Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Carbapenem Antibiotics Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Carbapenem Antibiotics Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Carbapenem Antibiotics Sales Breakdown by Type (2024-2024)
2 Global Carbapenem Antibiotics Market Competition by Company
2.1 Global Top Players by Carbapenem Antibiotics Sales (2024-2024)
2.2 Global Top Players by Carbapenem Antibiotics Revenue (2024-2024)
2.3 Global Top Players by Carbapenem Antibiotics Price (2024-2024)
2.4 Global Top Manufacturers Carbapenem Antibiotics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Carbapenem Antibiotics Market Competitive Situation and Trends
2.5.1 Carbapenem Antibiotics Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Carbapenem Antibiotics Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Carbapenem Antibiotics as of 2022)
2.7 Date of Key Manufacturers Enter into Carbapenem Antibiotics Market
2.8 Key Manufacturers Carbapenem Antibiotics Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Carbapenem Antibiotics Status and Outlook by Region
3.1 Global Carbapenem Antibiotics Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Carbapenem Antibiotics Historic Market Size by Region
3.2.1 Global Carbapenem Antibiotics Sales in Volume by Region (2024-2024)
3.2.2 Global Carbapenem Antibiotics Sales in Value by Region (2024-2024)
3.2.3 Global Carbapenem Antibiotics Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Carbapenem Antibiotics Forecasted Market Size by Region
3.3.1 Global Carbapenem Antibiotics Sales in Volume by Region (2024-2034)
3.3.2 Global Carbapenem Antibiotics Sales in Value by Region (2024-2034)
3.3.3 Global Carbapenem Antibiotics Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Carbapenem Antibiotics by Application
4.1 Carbapenem Antibiotics Market Segment by Application
4.1.1 Retail Pharmacy
4.1.2 Online Pharmacy
4.1.3 Hospital Pharmacy
4.2 Global Carbapenem Antibiotics Market Size by Application
4.2.1 Global Carbapenem Antibiotics Market Size Overview by Application (2024-2034)
4.2.2 Global Carbapenem Antibiotics Historic Market Size Review by Application (2024-2024)
4.2.3 Global Carbapenem Antibiotics Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Carbapenem Antibiotics Sales Breakdown by Application (2024-2024)
4.3.2 Europe Carbapenem Antibiotics Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Carbapenem Antibiotics Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Carbapenem Antibiotics Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Carbapenem Antibiotics Sales Breakdown by Application (2024-2024)
5 North America Carbapenem Antibiotics by Country
5.1 North America Carbapenem Antibiotics Historic Market Size by Country
5.1.1 North America Carbapenem Antibiotics Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Carbapenem Antibiotics Sales in Volume by Country (2024-2024)
5.1.3 North America Carbapenem Antibiotics Sales in Value by Country (2024-2024)
5.2 North America Carbapenem Antibiotics Forecasted Market Size by Country
5.2.1 North America Carbapenem Antibiotics Sales in Volume by Country (2024-2034)
5.2.2 North America Carbapenem Antibiotics Sales in Value by Country (2024-2034)
6 Europe Carbapenem Antibiotics by Country
6.1 Europe Carbapenem Antibiotics Historic Market Size by Country
6.1.1 Europe Carbapenem Antibiotics Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Carbapenem Antibiotics Sales in Volume by Country (2024-2024)
6.1.3 Europe Carbapenem Antibiotics Sales in Value by Country (2024-2024)
6.2 Europe Carbapenem Antibiotics Forecasted Market Size by Country
6.2.1 Europe Carbapenem Antibiotics Sales in Volume by Country (2024-2034)
6.2.2 Europe Carbapenem Antibiotics Sales in Value by Country (2024-2034)
7 Asia-Pacific Carbapenem Antibiotics by Region
7.1 Asia-Pacific Carbapenem Antibiotics Historic Market Size by Region
7.1.1 Asia-Pacific Carbapenem Antibiotics Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Carbapenem Antibiotics Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Carbapenem Antibiotics Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Carbapenem Antibiotics Forecasted Market Size by Region
7.2.1 Asia-Pacific Carbapenem Antibiotics Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Carbapenem Antibiotics Sales in Value by Region (2024-2034)
8 Latin America Carbapenem Antibiotics by Country
8.1 Latin America Carbapenem Antibiotics Historic Market Size by Country
8.1.1 Latin America Carbapenem Antibiotics Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Carbapenem Antibiotics Sales in Volume by Country (2024-2024)
8.1.3 Latin America Carbapenem Antibiotics Sales in Value by Country (2024-2024)
8.2 Latin America Carbapenem Antibiotics Forecasted Market Size by Country
8.2.1 Latin America Carbapenem Antibiotics Sales in Volume by Country (2024-2034)
8.2.2 Latin America Carbapenem Antibiotics Sales in Value by Country (2024-2034)
9 Middle East and Africa Carbapenem Antibiotics by Country
9.1 Middle East and Africa Carbapenem Antibiotics Historic Market Size by Country
9.1.1 Middle East and Africa Carbapenem Antibiotics Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Carbapenem Antibiotics Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Carbapenem Antibiotics Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Carbapenem Antibiotics Forecasted Market Size by Country
9.2.1 Middle East and Africa Carbapenem Antibiotics Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Carbapenem Antibiotics Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 ACS Dobfar S.p.A
10.1.1 ACS Dobfar S.p.A Company Information
10.1.2 ACS Dobfar S.p.A Introduction and Business Overview
10.1.3 ACS Dobfar S.p.A Carbapenem Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.1.4 ACS Dobfar S.p.A Carbapenem Antibiotics Products Offered
10.1.5 ACS Dobfar S.p.A Recent Development
10.2 Iterum Therapeutics plc
10.2.1 Iterum Therapeutics plc Company Information
10.2.2 Iterum Therapeutics plc Introduction and Business Overview
10.2.3 Iterum Therapeutics plc Carbapenem Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Iterum Therapeutics plc Carbapenem Antibiotics Products Offered
10.2.5 Iterum Therapeutics plc Recent Development
10.3 DAEWOONG PHARMACEUTICAL CO.,LTD
10.3.1 DAEWOONG PHARMACEUTICAL CO.,LTD Company Information
10.3.2 DAEWOONG PHARMACEUTICAL CO.,LTD Introduction and Business Overview
10.3.3 DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.3.4 DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem Antibiotics Products Offered
10.3.5 DAEWOONG PHARMACEUTICAL CO.,LTD Recent Development
10.4 Aurobindo Pharma Ltd
10.4.1 Aurobindo Pharma Ltd Company Information
10.4.2 Aurobindo Pharma Ltd Introduction and Business Overview
10.4.3 Aurobindo Pharma Ltd Carbapenem Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Aurobindo Pharma Ltd Carbapenem Antibiotics Products Offered
10.4.5 Aurobindo Pharma Ltd Recent Development
10.5 Gland Pharma Limited
10.5.1 Gland Pharma Limited Company Information
10.5.2 Gland Pharma Limited Introduction and Business Overview
10.5.3 Gland Pharma Limited Carbapenem Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Gland Pharma Limited Carbapenem Antibiotics Products Offered
10.5.5 Gland Pharma Limited Recent Development
10.6 Merck & Co., Inc.
10.6.1 Merck & Co., Inc. Company Information
10.6.2 Merck & Co., Inc. Introduction and Business Overview
10.6.3 Merck & Co., Inc. Carbapenem Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Merck & Co., Inc. Carbapenem Antibiotics Products Offered
10.6.5 Merck & Co., Inc. Recent Development
10.7 Sumitomo Dainippon Pharma Co., Ltd.
10.7.1 Sumitomo Dainippon Pharma Co., Ltd. Company Information
10.7.2 Sumitomo Dainippon Pharma Co., Ltd. Introduction and Business Overview
10.7.3 Sumitomo Dainippon Pharma Co., Ltd. Carbapenem Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Sumitomo Dainippon Pharma Co., Ltd. Carbapenem Antibiotics Products Offered
10.7.5 Sumitomo Dainippon Pharma Co., Ltd. Recent Development
10.8 Savior Lifetec
10.8.1 Savior Lifetec Company Information
10.8.2 Savior Lifetec Introduction and Business Overview
10.8.3 Savior Lifetec Carbapenem Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Savior Lifetec Carbapenem Antibiotics Products Offered
10.8.5 Savior Lifetec Recent Development
10.9 Pfizer Inc.
10.9.1 Pfizer Inc. Company Information
10.9.2 Pfizer Inc. Introduction and Business Overview
10.9.3 Pfizer Inc. Carbapenem Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Pfizer Inc. Carbapenem Antibiotics Products Offered
10.9.5 Pfizer Inc. Recent Development
10.10 Spero Therapeutics
10.10.1 Spero Therapeutics Company Information
10.10.2 Spero Therapeutics Introduction and Business Overview
10.10.3 Spero Therapeutics Carbapenem Antibiotics Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Spero Therapeutics Carbapenem Antibiotics Products Offered
10.10.5 Spero Therapeutics Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Carbapenem Antibiotics Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Carbapenem Antibiotics Industrial Chain Analysis
11.4 Carbapenem Antibiotics Market Dynamics
11.4.1 Carbapenem Antibiotics Industry Trends
11.4.2 Carbapenem Antibiotics Market Drivers
11.4.3 Carbapenem Antibiotics Market Challenges
11.4.4 Carbapenem Antibiotics Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Carbapenem Antibiotics Distributors
12.3 Carbapenem Antibiotics Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Meropenem
Table 2. Major Company of Donipenem
Table 3. Major Company of Imipenem
Table 4. Major Company of Tipipenem
Table 5. Major Company of Others
Table 6. Global Carbapenem Antibiotics Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 7. Global Carbapenem Antibiotics Sales by Type (2024-2024) & (Tons)
Table 8. Global Carbapenem Antibiotics Sales Market Share in Volume by Type (2024-2024)
Table 9. Global Carbapenem Antibiotics Sales by Type (2024-2024) & (US& Million)
Table 10. Global Carbapenem Antibiotics Market Share in Value by Type (2024-2024)
Table 11. Global Carbapenem Antibiotics Price by Type (2024-2024) & (US$/Kg)
Table 12. Global Carbapenem Antibiotics Sales by Type (2024-2034) & (Tons)
Table 13. Global Carbapenem Antibiotics Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Carbapenem Antibiotics Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Carbapenem Antibiotics Sales Market Share in Value by Type (2024-2034)
Table 16. Global Carbapenem Antibiotics Price by Type (2024-2034) & (US$/Kg)
Table 17. North America Carbapenem Antibiotics Sales by Type (2024-2024) & (Tons)
Table 18. North America Carbapenem Antibiotics Sales by Type (2024-2024) & (US$ Million)
Table 19. Europe Carbapenem Antibiotics Sales (Tons) by Type (2024-2024)
Table 20. Europe Carbapenem Antibiotics Sales by Type (2024-2024) & (US$ Million)
Table 21. Asia-Pacific Carbapenem Antibiotics Sales (Tons) by Type (2024-2024)
Table 22. Asia-Pacific Carbapenem Antibiotics Sales by Type (2024-2024) & (US$ Million)
Table 23. Latin America Carbapenem Antibiotics Sales (Tons) by Type (2024-2024)
Table 24. Latin America Carbapenem Antibiotics Sales by Type (2024-2024) & (US$ Million)
Table 25. Middle East and Africa Carbapenem Antibiotics Sales (Tons) by Type (2024-2024)
Table 26. Middle East and Africa Carbapenem Antibiotics Sales by Type (2024-2024) & (US$ Million)
Table 27. Global Carbapenem Antibiotics Sales by Company (2024-2024) & (Tons)
Table 28. Global Carbapenem Antibiotics Sales Share by Company (2024-2024)
Table 29. Global Carbapenem Antibiotics Revenue by Company (2024-2024) & (US$ Million)
Table 30. Global Carbapenem Antibiotics Revenue Share by Company (2024-2024)
Table 31. Global Market Carbapenem Antibiotics Price by Company (2024-2024) & (US$/Kg)
Table 32. Global Carbapenem Antibiotics Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Carbapenem Antibiotics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Carbapenem Antibiotics as of 2022)
Table 35. Date of Key Manufacturers Enter into Carbapenem Antibiotics Market
Table 36. Key Manufacturers Carbapenem Antibiotics Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Carbapenem Antibiotics Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 39. Global Carbapenem Antibiotics Sales by Region (2024-2024) & (Tons)
Table 40. Global Carbapenem Antibiotics Sales Market Share in Volume by Region (2024-2024)
Table 41. Global Carbapenem Antibiotics Sales by Region (2024-2024) & (US$ Million)
Table 42. Global Carbapenem Antibiotics Sales Market Share in Value by Region (2024-2024)
Table 43. Global Carbapenem Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 44. Global Carbapenem Antibiotics Sales by Region (2024-2034) & (Tons)
Table 45. Global Carbapenem Antibiotics Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Carbapenem Antibiotics Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Carbapenem Antibiotics Sales Market Share in Value by Region (2024-2034)
Table 48. Global Carbapenem Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2034)
Table 49. Global Carbapenem Antibiotics Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 50. Global Carbapenem Antibiotics Sales by Application (2024-2024) & (Tons)
Table 51. Global Carbapenem Antibiotics Sales Market Share in Volume by Application (2024-2024)
Table 52. Global Carbapenem Antibiotics Sales by Application (2024-2024) & (US$ Million)
Table 53. Global Carbapenem Antibiotics Sales Market Share in Value by Application (2024-2024)
Table 54. Global Carbapenem Antibiotics Price by Application (2024-2024) & (US$/Kg)
Table 55. Global Carbapenem Antibiotics Sales by Application (2024-2034) & (Tons)
Table 56. Global Carbapenem Antibiotics Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Carbapenem Antibiotics Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Carbapenem Antibiotics Sales Market Share in Value by Application (2024-2034)
Table 59. Global Carbapenem Antibiotics Price by Application (2024-2034) & (US$/Kg)
Table 60. North America Carbapenem Antibiotics Sales by Application (2024-2024) (Tons)
Table 61. North America Carbapenem Antibiotics Sales by Application (2024-2024) & (US$ Million)
Table 62. Europe Carbapenem Antibiotics Sales by Application (2024-2024) (Tons)
Table 63. Europe Carbapenem Antibiotics Sales by Application (2024-2024) & (US$ Million)
Table 64. Asia-Pacific Carbapenem Antibiotics Sales by Application (2024-2024) (Tons)
Table 65. Asia-Pacific Carbapenem Antibiotics Sales by Application (2024-2024) & (US$ Million)
Table 66. Latin America Carbapenem Antibiotics Sales by Application (2024-2024) (Tons)
Table 67. Latin America Carbapenem Antibiotics Sales by Application (2024-2024) & (US$ Million)
Table 68. Middle East and Africa Carbapenem Antibiotics Sales by Application (2024-2024) (Tons)
Table 69. Middle East and Africa Carbapenem Antibiotics Sales by Application (2024-2024) & (US$ Million)
Table 70. North America Carbapenem Antibiotics Sales by Country (2024-2024) & (Tons)
Table 71. North America Carbapenem Antibiotics Sales Market Share in Volume by Country (2024-2024)
Table 72. North America Carbapenem Antibiotics Sales by Country (2024-2024) & (US$ Million)
Table 73. North America Carbapenem Antibiotics Sales Market Share in Value by Country (2024-2024)
Table 74. North America Carbapenem Antibiotics Sales by Country (2024-2034) & (Tons)
Table 75. North America Carbapenem Antibiotics Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Carbapenem Antibiotics Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Carbapenem Antibiotics Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Carbapenem Antibiotics Sales by Country (2024-2024) & (Tons)
Table 79. Europe Carbapenem Antibiotics Sales Market Share in Volume by Country (2024-2024)
Table 80. Europe Carbapenem Antibiotics Sales by Country (2024-2024) & (US$ Million)
Table 81. Europe Carbapenem Antibiotics Sales Market Share in Value by Country (2024-2024)
Table 82. Europe Carbapenem Antibiotics Sales by Country (2024-2034) & (Tons)
Table 83. Europe Carbapenem Antibiotics Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Carbapenem Antibiotics Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Carbapenem Antibiotics Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Carbapenem Antibiotics Sales by Region (2024-2024) & (Tons)
Table 87. Asia-Pacific Carbapenem Antibiotics Sales Market Share in Volume by Region (2024-2024)
Table 88. Asia-Pacific Carbapenem Antibiotics Sales by Region (2024-2024) & (US$ Million)
Table 89. Asia-Pacific Carbapenem Antibiotics Sales Market Share in Value by Region (2024-2024)
Table 90. Asia-Pacific Carbapenem Antibiotics Sales by Region (2024-2034) & (Tons)
Table 91. Asia-Pacific Carbapenem Antibiotics Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Carbapenem Antibiotics Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Carbapenem Antibiotics Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Carbapenem Antibiotics Sales by Country (2024-2024) & (Tons)
Table 95. Latin America Carbapenem Antibiotics Sales Market Share in Volume by Country (2024-2024)
Table 96. Latin America Carbapenem Antibiotics Sales by Country (2024-2024) & (US$ Million)
Table 97. Latin America Carbapenem Antibiotics Sales Market Share in Value by Country (2024-2024)
Table 98. Latin America Carbapenem Antibiotics Sales by Country (2024-2034) & (Tons)
Table 99. Latin America Carbapenem Antibiotics Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Carbapenem Antibiotics Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Carbapenem Antibiotics Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Carbapenem Antibiotics Sales by Country (2024-2024) & (Tons)
Table 103. Middle East and Africa Carbapenem Antibiotics Sales Market Share in Volume by Country (2024-2024)
Table 104. Middle East and Africa Carbapenem Antibiotics Sales by Country (2024-2024) & (US$ Million)
Table 105. Middle East and Africa Carbapenem Antibiotics Sales Market Share in Value by Country (2024-2024)
Table 106. Middle East and Africa Carbapenem Antibiotics Sales by Country (2024-2034) & (Tons)
Table 107. Middle East and Africa Carbapenem Antibiotics Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Carbapenem Antibiotics Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Carbapenem Antibiotics Sales Market Share in Value by Country (2024-2034)
Table 110. ACS Dobfar S.p.A Company Information
Table 111. ACS Dobfar S.p.A Introduction and Business Overview
Table 112. ACS Dobfar S.p.A Carbapenem Antibiotics Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 113. ACS Dobfar S.p.A Carbapenem Antibiotics Product
Table 114. ACS Dobfar S.p.A Recent Development
Table 115. Iterum Therapeutics plc Company Information
Table 116. Iterum Therapeutics plc Introduction and Business Overview
Table 117. Iterum Therapeutics plc Carbapenem Antibiotics Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 118. Iterum Therapeutics plc Carbapenem Antibiotics Product
Table 119. Iterum Therapeutics plc Recent Development
Table 120. DAEWOONG PHARMACEUTICAL CO.,LTD Company Information
Table 121. DAEWOONG PHARMACEUTICAL CO.,LTD Introduction and Business Overview
Table 122. DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem Antibiotics Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 123. DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem Antibiotics Product
Table 124. DAEWOONG PHARMACEUTICAL CO.,LTD Recent Development
Table 125. Aurobindo Pharma Ltd Company Information
Table 126. Aurobindo Pharma Ltd Introduction and Business Overview
Table 127. Aurobindo Pharma Ltd Carbapenem Antibiotics Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 128. Aurobindo Pharma Ltd Carbapenem Antibiotics Product
Table 129. Aurobindo Pharma Ltd Recent Development
Table 130. Gland Pharma Limited Company Information
Table 131. Gland Pharma Limited Introduction and Business Overview
Table 132. Gland Pharma Limited Carbapenem Antibiotics Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 133. Gland Pharma Limited Carbapenem Antibiotics Product
Table 134. Gland Pharma Limited Recent Development
Table 135. Merck & Co., Inc. Company Information
Table 136. Merck & Co., Inc. Introduction and Business Overview
Table 137. Merck & Co., Inc. Carbapenem Antibiotics Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 138. Merck & Co., Inc. Carbapenem Antibiotics Product
Table 139. Merck & Co., Inc. Recent Development
Table 140. Sumitomo Dainippon Pharma Co., Ltd. Company Information
Table 141. Sumitomo Dainippon Pharma Co., Ltd. Introduction and Business Overview
Table 142. Sumitomo Dainippon Pharma Co., Ltd. Carbapenem Antibiotics Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 143. Sumitomo Dainippon Pharma Co., Ltd. Carbapenem Antibiotics Product
Table 144. Sumitomo Dainippon Pharma Co., Ltd. Recent Development
Table 145. Savior Lifetec Company Information
Table 146. Savior Lifetec Introduction and Business Overview
Table 147. Savior Lifetec Carbapenem Antibiotics Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 148. Savior Lifetec Carbapenem Antibiotics Product
Table 149. Savior Lifetec Recent Development
Table 150. Pfizer Inc. Company Information
Table 151. Pfizer Inc. Introduction and Business Overview
Table 152. Pfizer Inc. Carbapenem Antibiotics Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 153. Pfizer Inc. Carbapenem Antibiotics Product
Table 154. Pfizer Inc. Recent Development
Table 155. Spero Therapeutics Company Information
Table 156. Spero Therapeutics Introduction and Business Overview
Table 157. Spero Therapeutics Carbapenem Antibiotics Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 158. Spero Therapeutics Carbapenem Antibiotics Product
Table 159. Spero Therapeutics Recent Development
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Carbapenem Antibiotics Market Trends
Table 163. Carbapenem Antibiotics Market Drivers
Table 164. Carbapenem Antibiotics Market Challenges
Table 165. Carbapenem Antibiotics Market Restraints
Table 166. Carbapenem Antibiotics Distributors List
Table 167. Carbapenem Antibiotics Downstream Customers
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Carbapenem Antibiotics Product Picture
Figure 2. Global Carbapenem Antibiotics Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Carbapenem Antibiotics Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Carbapenem Antibiotics Sales Status and Outlook (2024-2034) & (Tons)
Figure 5. Product Picture of Meropenem
Figure 6. Global Meropenem Sales YoY Growth (2024-2034) & (Tons)
Figure 7. Product Picture of Donipenem
Figure 8. Global Donipenem Sales YoY Growth (2024-2034) & (Tons)
Figure 9. Product Picture of Imipenem
Figure 10. Global Imipenem Sales YoY Growth (2024-2034) & (Tons)
Figure 11. Product Picture of Tipipenem
Figure 12. Global Tipipenem Sales YoY Growth (2024-2034) & (Tons)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2024-2034) & (Tons)
Figure 15. Global Carbapenem Antibiotics Sales by Type (2024-2034) & (US$ Million)
Figure 16. Global Carbapenem Antibiotics Sales Market Share by Type in 2022 & 2034
Figure 17. North America Carbapenem Antibiotics Sales Market Share in Volume by Type in 2022
Figure 18. North America Carbapenem Antibiotics Sales Market Share in Value by Type in 2022
Figure 19. Europe Carbapenem Antibiotics Sales Market Share in Volume by Type in 2022
Figure 20. Europe Carbapenem Antibiotics Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Carbapenem Antibiotics Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Carbapenem Antibiotics Sales Market Share in Value by Type in 2022
Figure 23. Latin America Carbapenem Antibiotics Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Carbapenem Antibiotics Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Carbapenem Antibiotics Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Carbapenem Antibiotics Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Carbapenem Antibiotics Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Carbapenem Antibiotics Revenue in 2022
Figure 29. Carbapenem Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 30. Product Picture of Retail Pharmacy
Figure 31. Global Retail Pharmacy Sales YoY Growth (2024-2034) & (Tons)
Figure 32. Product Picture of Online Pharmacy
Figure 33. Global Online Pharmacy Sales YoY Growth (2024-2034) & (Tons)
Figure 34. Product Picture of Hospital Pharmacy
Figure 35. Global Hospital Pharmacy Sales YoY Growth (2024-2034) & (Tons)
Figure 36. Global Carbapenem Antibiotics Sales by Application (2024-2034) & (US$ Million)
Figure 37. Global Carbapenem Antibiotics Sales Market Share by Application in 2022 & 2034
Figure 38. North America Carbapenem Antibiotics Sales Market Share in Volume by Application in 2022
Figure 39. North America Carbapenem Antibiotics Sales Market Share in Value by Application in 2022
Figure 40. Europe Carbapenem Antibiotics Sales Market Share in Volume by Application in 2022
Figure 41. Europe Carbapenem Antibiotics Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Carbapenem Antibiotics Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Carbapenem Antibiotics Sales Market Share in Value by Application in 2022
Figure 44. Latin America Carbapenem Antibiotics Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Carbapenem Antibiotics Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Carbapenem Antibiotics Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Carbapenem Antibiotics Manufacturing Cost Structure
Figure 49. Carbapenem Antibiotics Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries